| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4268422 | British Journal of Medical and Surgical Urology | 2010 | 8 Pages |
Abstract
During a six week regimen, the side effects of intravesical BCG immunotherapy become significant in the 2nd week of treatment and are worst on day two post-instillation. The severity of symptoms increases throughout the course of the treatment. A one hour treatment regimen produced a more significant side effect profile in terms of frequency, urgency, dysuria and arthralgia when compared to the two hour regimen. There was no detectable difference in clinical outcomes observed between the two groups. Continuing the practice of a two hour BCG instillation regimen is therefore recommended.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
J.R.F. Wilson, B.W. Turney, K. LeMonnier, J.P. Crew,